Definium Therapeutics DFTX
NASDAQ DFTX
$34.56 -0.08 (-0.23%)
As of: Nov 11, 2026 · 11:34 AM EST

Definium Therapeutics (DFTX) Amortization - Intangibles (2020 - 2021)

Updated

Analysis

Definium Therapeutics (DFTX) Amortization - Intangibles (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Definium Therapeutics 4.74 Bn 1.83 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 3.26 Mn
Jun 30, 2021 3.26 Mn
Mar 31, 2021 1.18 Mn
Sep 30, 2020 137,000.00
Jun 30, 2020 138,000.00
Mar 31, 2020 138,000.00
API Access

Definium Therapeutics Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=DFTX&period=max&api_key=YOUR_API_KEY